- Home
- APLM vs EDBL Comparison
APLM vs EDBL Comparison
Compare APLM & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- EDBL
- Stock Information
- Founded
- APLM 2016
- EDBL 2020
- Country
- APLM United States
- EDBL United States
- Employees
- APLM N/A
- EDBL N/A
- Industry
- APLM Blank Checks
- EDBL Farming/Seeds/Milling
- Sector
- APLM Finance
- EDBL Consumer Staples
- Exchange
- APLM Nasdaq
- EDBL Nasdaq
- Market Cap
- APLM 6.1M
- EDBL 5.7M
- IPO Year
- APLM N/A
- EDBL 2022
- Fundamental
- Price
- APLM $18.43
- EDBL $1.77
- Analyst Decision
- APLM
- EDBL
- Analyst Count
- APLM 0
- EDBL 0
- Target Price
- APLM N/A
- EDBL N/A
- AVG Volume (30 Days)
- APLM 89.6K
- EDBL 285.5K
- Earning Date
- APLM 09-30-2025
- EDBL 11-12-2025
- Dividend Yield
- APLM N/A
- EDBL N/A
- EPS Growth
- APLM N/A
- EDBL N/A
- EPS
- APLM N/A
- EDBL N/A
- Revenue
- APLM $198,000.00
- EDBL $12,320,000.00
- Revenue This Year
- APLM $415.15
- EDBL $29.56
- Revenue Next Year
- APLM N/A
- EDBL $20.00
- P/E Ratio
- APLM N/A
- EDBL N/A
- Revenue Growth
- APLM N/A
- EDBL N/A
- 52 Week Low
- APLM $3.66
- EDBL $1.68
- 52 Week High
- APLM $35.98
- EDBL $25.00
- Technical
- Relative Strength Index (RSI)
- APLM 90.29
- EDBL 29.14
- Support Level
- APLM $3.66
- EDBL $1.74
- Resistance Level
- APLM $6.37
- EDBL $1.88
- Average True Range (ATR)
- APLM 1.65
- EDBL 0.14
- MACD
- APLM 1.20
- EDBL 0.02
- Stochastic Oscillator
- APLM 85.30
- EDBL 9.57
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.